ABSTRACT
Objective
To investigate cyclophilin A in early second trimester of pregnancy before the onset of preeclampsia.
Methods
In this prospective case-control study, 51 pregnant women whose serum were collected and stored and who developed preeclampsia in later follow-up and 41 pregnant women as control group were included.
Results
Maternal serum cyclophilin A levels in the study group who developed preeclampsia in later follow-up were significantly higher than those of normal healthy pregnant women.
Conclusion
Cyclophilin A may be a valuable predictor for pregnant women who subsequently develop preeclampsia in their pregnancies.
Data availability statement
All relevant clinical and biological data are available within the article, or available from the authors upon a reasonable request.
Disclosure statement
All the authors declare there are no potential conflicts of interest exist with respect to the research, authorship, and/or publication of this article.